Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
Background: In December 2020, Moderna released the mRNA-1273 vaccine. The most common side effects are headache, muscle pain, redness, swelling, and tenderness at the injection site. In addition, there have been dermatological adverse events, such as hypersensitivity reactions. Although rare, variou...
Saved in:
Main Authors: | Joyce Kong (Author), Francisco Cuevas-Castillo (Author), Mahmoud Nassar (Author), Chi M. Lei (Author), Zarwa Idrees (Author), William C. Fix (Author), Caroline Halverstam (Author), Adnan Mir (Author), Amira Elbendary (Author), Alwin Mathew (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dyshidrotic bullous pemphigoid developing after Moderna mRNA-1273 vaccination
by: Tyng-Shiuan Hsieh, et al.
Published: (2023) -
Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
by: Elif Karatas, MD, et al.
Published: (2023) -
Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
by: Leelakrishna Channa, BS, et al.
Published: (2021) -
Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review
by: Angel Shabu, et al.
Published: (2023) -
Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
by: Masahiro Iwata, et al.
Published: (2023)